Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
ClinicalTrials.gov study NCT05413018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm
ClinicalTrials.gov study NCT02159495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01843634. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06537843. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01701323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07014462. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review
ClinicalTrials.gov study NCT03047083. IPD Sharing: NO. Countries: 1. Publications: 0.
Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03433521. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04956042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00002805. IPD Sharing: Not stated. Countries: 3. Publications: 0.
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01041443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03661307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07177079. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
ClinicalTrials.gov study NCT06279572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Invasives Aspergillosis in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02900430. IPD Sharing: NO. Countries: 1. Publications: 0.
Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06643195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00100971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.
ClinicalTrials.gov study NCT03217838. IPD Sharing: YES. Countries: 2. Publications: 0.
Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01066286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
ClinicalTrials.gov study NCT03603795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.